E-LIB Suche - Ergebnisse für: Karp, Daniel D.

1

Simultaneous submission of seven CTSA proposals: UM1, K12, ..:

Lema, Carolina ; Cheng, Kwai Wa ; Anderson, Delanderia M....
Journal of Clinical and Translational Science. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..

2

Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in c..:

Coleman, Niamh ; Stephen, Bettzy ; Fu, Siqing...
Cancer Medicine. 13 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

3

First-In-Human Phase I Study of Tinengotinib (TT-00420), a ..:

Piha-Paul, Sarina A ; Xu, Binghe ; Dumbrava, Ecaterina E...
The Oncologist. 29 (2024) 4 - p. e514-e525 , 2024

Link: https://doi.org/10.1093/..

4

Impact of Biomarker-Matched Therapies on Outcomes in Patien..:

Carmagnani Pestana, Roberto ; Moyers, Justin T. ; Roszik, Jason...
Clinical Cancer Research. 29 (2023) 9 - p. 1708-1718 , 2023

Link: https://doi.org/10.1158/..

5

Phase 1b study of combined selinexor and eribulin for the t..:

Nelson, Blessie Elizabeth ; Saleem, Sadia ; Damodaran, Senthil...
Cancer. 129 (2023) 14 - p. 2201-2213 , 2023

Link: https://doi.org/10.1002/..

6

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB..:

Knisely, Anne ; Ahmed, Jibran ; Stephen, Bettzy...
Cancer. 130 (2023) 3 - p. 400-409 , 2023

Link: https://doi.org/10.1002/..

7

A Phase I Trial of Bevacizumab and Temsirolimus in Combinat..:

Nelson, Blessie Elizabeth ; Tsimberidou, Apostolia M ; Fu, Xueyao...
The Oncologist. 28 (2023) 12 - p. 1100-e1292 , 2023

Link: https://doi.org/10.1093/..

8

A phase I trial of the pan-ERBB inhibitor neratinib combine..:

Piha-Paul, Sarina A. ; Tseng, Chieh ; Tran, Hai T....
Cancer Chemotherapy and Pharmacology. 92 (2023) 2 - p. 107-118 , 2023

Link: https://doi.org/10.1007/..

9

Safety, tolerability, and clinical activity of selinexor in..:

Altan, Mehmet ; Tu, Janet ; Milton, Denái R....
Cancer. 129 (2023) 17 - p. 2685-2693 , 2023

Link: https://doi.org/10.1002/..

10

Complex I inhibitor of oxidative phosphorylation in advance..:

Yap, Timothy A. ; Daver, Naval ; Mahendra, Mikhila...
Nature Medicine. , 2023

Link: https://doi.org/10.1038/..

11

SOLAR: Phase Ib Dose Expansion of Selumetinib (MEK Inhibito..:

Westin, Shannon ; Kurnit, Katherine ; Fellman, Bryan...
Gynecologic Oncology. 176 (2023) - p. S33 , 2023

Link: https://doi.org/10.1016/..

12

Predictors of Oncologic Outcome in Patients Receiving Phase..:

Son, Ji ; Lin, Heather Y. ; Fu, Siqing...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 1 - p. 10-18 , 2023

Link: https://doi.org/10.36401..

13

Long COVID in cancer patients: preponderance of symptoms in..:

Dagher, Hiba ; Chaftari, Anne-Marie ; Subbiah, Ishwaria M...
eLife. 12 (2023) - p. , 2023

Link: https://doi.org/10.7554/..

14

Challenges and opportunities associated with the MD Anderso..:

Vo, Henry Hiep ; Fu, Siqing ; Hong, David S....
npj Precision Oncology. 6 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

15

Patient-reported symptom burden in patients with rare cance..:

Mendoza, Tito R. ; Hong, David S. ; Peterson, Christine B....
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..